Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Haisco Pharmaceutical Group Co Ltd banner

Haisco Pharmaceutical Group Co Ltd
SZSE:002653

Watchlist Manager
Haisco Pharmaceutical Group Co Ltd Logo
Haisco Pharmaceutical Group Co Ltd
SZSE:002653
Watchlist
Price: 47.96 CNY -2.32% Market Closed
Market Cap: ¥53.7B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Haisco Pharmaceutical Group Co Ltd

Wall Street analysts forecast Haisco Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Haisco Pharmaceutical Group Co Ltd is 94.74 CNY with a low forecast of 93.81 CNY and a high forecast of 97.52 CNY.

Lowest Forecast
Wall Street Target
93.81 CNY
96% Upside
Average Forecast
Wall Street Target
94.74 CNY
98% Upside
Highest Forecast
Wall Street Target
97.52 CNY
103% Upside
Lowest
Price Target
93.81 CNY
96% Upside
Average
Price Target
94.74 CNY
98% Upside
Highest
Price Target
97.52 CNY
103% Upside
Haisco Pharmaceutical Group Co Ltd Competitors:
Price Targets
M
M3C0
Mitsubishi Chemical Group Corp
-16% Downside
M
M3C0
Mitsubishi Chemical Group Corp
-16% Downside

Revenue
Forecast

15% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
15% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 13 years the compound annual growth rate for Haisco Pharmaceutical Group Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 22%.

What are analyst estimates?

Operating Income
Forecast

2% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
2% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

For the last 13 years the compound annual growth rate for Haisco Pharmaceutical Group Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 40%.

What are analyst estimates?

Net Income
Forecast

2% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
2% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 13 years the compound annual growth rate for Haisco Pharmaceutical Group Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 34%.

What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Haisco Pharmaceutical Group Co Ltd's stock price target?
Price Target
94.74 CNY

According to Wall Street analysts, the average 1-year price target for Haisco Pharmaceutical Group Co Ltd is 94.74 CNY with a low forecast of 93.81 CNY and a high forecast of 97.52 CNY.

What is Haisco Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for Haisco Pharmaceutical Group Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 22%.

What is Haisco Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
40%

For the last 13 years the compound annual growth rate for Haisco Pharmaceutical Group Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 40%.

What is Haisco Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
34%

For the last 13 years the compound annual growth rate for Haisco Pharmaceutical Group Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 34%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.